Company · CIK 0001853816 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Dermata Therapeutics, Inc. · DRMA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2026 AForm 4 → | Aug 18, 5:25 pm EDT | Gerald T ProehlPRESIDENT, CHAIRMAN, CEO, Director, 10% Owner | 170,068 | — | — | 292,631 | — | |
| Aug 16, 2026 AForm 4 → | Aug 18, 5:21 pm EDT | Kyri K. Van HooseSVP, CFO | 102,040 | — | — | 232,463 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2026 AForm 4 → | Aug 18, 5:25 pm EDT | Gerald T ProehlPRESIDENT, CHAIRMAN, CEO, Director, 10% Owner | 4,421,768 | — | — | 1,360,544 | — | |
| Aug 16, 2026 AForm 4 → | Aug 18, 5:21 pm EDT | Kyri K. Van HooseSVP, CFO | 204,080 | — | — | 102,040 | — |